AAAAAA
Results:
1-14
|
Results: 14
Authors:
JANSEN G
PETERS GJ
KATHMANN I
BORITZKI TJ
JACKSON RC
Citation: G. Jansen et al., MEMBRANE-TRANSPORT AND BIOLOGICAL-ACTIVITY OF STEREOISOMERS AG2032 AND AG2034 - NOVEL INHIBITORS OF GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE, Annals of oncology, 9, 1998, pp. 590-590
Authors:
ZHANG CC
BORITZKI TJ
JACKSON RC
Citation: Cc. Zhang et al., AN INHIBITOR OF GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE IS SELECTIVELY CYTOTOXIC TO CELLS THAT LACK A FUNCTIONAL G1 CHECKPOINT, Cancer chemotherapy and pharmacology, 41(3), 1998, pp. 223-228
Authors:
FAESSEL HM
SLOCUM HK
JACKSON RC
BORITZKI TJ
RUSTUM YM
NAIR MG
GRECO WR
Citation: Hm. Faessel et al., SUPER IN-VITRO SYNERGY BETWEEN INHIBITORS OF DIHYDROFOLATE-REDUCTASE AND INHIBITORS OF OTHER FOLATE-REQUIRING ENZYMES - THE CRITICAL ROLE OF POLYGLUTAMYLATION, Cancer research, 58(14), 1998, pp. 3036-3050
Authors:
JACKSON RC
Citation: Rc. Jackson, CONTRIBUTIONS OF PROTEIN STRUCTURE-BASED DRUG DESIGN TO CANCER-CHEMOTHERAPY, Seminars in oncology, 24(2), 1997, pp. 164-172
Authors:
JACKSON RC
Citation: Rc. Jackson, A PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION THAT RELATES DEVELOPMENT OF DRUG-RESISTANCE TO TREATMENT INTENSITY, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 713-730
Authors:
BORITZKI TJ
BARLETT CA
ZHANG C
HOWLAND EE
MARGOSIAK SA
PALMER CL
ROMINES WH
JACKSON RC
Citation: Tj. Boritzki et al., AG2034 - A NOVEL INHIBITOR OF GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE, Investigational new drugs, 14(3), 1996, pp. 295-303
Authors:
JACKSON RC
JACKSON JW
Citation: Rc. Jackson et Jw. Jackson, GENE SEGREGATION IN AUTOTETRAPLOIDS - PREDICTION FROM MEIOTIC CONFIGURATIONS, American journal of botany, 83(6), 1996, pp. 673-678
Authors:
RAFI I
TAYLOR GA
CALVETE JA
BODDY AV
BALMANNO K
BAILEY N
LIND M
CALVERT AH
WEBBER S
JACKSON RC
JOHNSTON A
CLENDENINN N
NEWELL DR
Citation: I. Rafi et al., CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR AMINO-6-METHYL-4-OXO-5-(4-PYRIDPLTHIO)-QUINAZOLONE DIHYDROCHLORIDE (AG337) GIVEN BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Clinical cancer research, 1(11), 1995, pp. 1275-1284
Authors:
JACKSON RC
Citation: Rc. Jackson, TOXICITY PREDICTION FROM METABOLIC PATHWAY MODELING, Toxicology, 102(1-2), 1995, pp. 197-205
Authors:
JACKSON RC
POLANYI JC
SJOVALL P
Citation: Rc. Jackson et al., PHOTODISSOCIATION DYNAMICS OF (NO)(2) ON LIF(001) - CHARACTERIZATION OF VIBRATIONALLY EXCITED NO FRAGMENTS, The Journal of chemical physics, 102(15), 1995, pp. 6308-6326
Authors:
OCONNOR BM
WEBBER S
JACKSON RC
GALIVAN J
RHEE MS
Citation: Bm. Oconnor et al., BIOLOGICAL-ACTIVITY OF A NOVEL RATIONALLY DESIGNED LIPOPHILIC THYMIDYLATE SYNTHASE INHIBITOR, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 225-229
Authors:
JACKSON RC
HAUBER DP
Citation: Rc. Jackson et Dp. Hauber, QUANTITATIVE CYTOGENETIC ANALYSES OF AUTOPLOID AND ALLOPLOID TAXA IN THE HELIANTHUS-CILIARIS GROUP (COMPOSITAE), American journal of botany, 81(8), 1994, pp. 1063-1069
Authors:
FRY DW
BORITZKI TJ
JACKSON RC
COOK PD
LEOPOLD WR
Citation: Dw. Fry et al., INHIBITION OF 5-PHOSPHORIBOSYL-1-PYROPHOSPHATE SYNTHETASE BY THE MONOPHOSPHATE METABOLITE OF ETA-D-RIBOFURANOSYLAMINO)PYRIMIDO[5,4-D]PYRIMIDINE - A NOVEL MECHANISM FOR ANTITUMOR-ACTIVITY, Molecular pharmacology, 44(2), 1993, pp. 479-485
Authors:
JACKSON RC
Citation: Rc. Jackson, AMPHIBOLIC DRUG-COMBINATIONS - THE DESIGN OF SELECTIVE ANTIMETABOLITEPROTOCOLS BASED UPON THE KINETIC-PROPERTIES OF MULTIENZYME SYSTEMS, Cancer research, 53(17), 1993, pp. 3998-4003
Risultati:
1-14
|